⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Global Orphan Drugs Market to Surpass USD 443 Billion by 2031 Driven by Advances in Genomics and Precision Medicine
globenewswire.com
AZN
NVS
Global Mantle Cell Lymphoma Market Set for Robust 7.91% CAGR Growth Through 2031
globenewswire.com
AZN
GILD
LLY
XBOW任命WonLae Lee為韓國區總經理
businesswire.com
GOOG
MSFT
AMZN
META
NVDA
IBM
ORCL
CSCO
ADBE
CRM
INTC
AMD
QCOM
MU
AMAT
LRCX
KLAC
TXN
ADI
NXPI
ON
MPWR
AEHR
TER
ASML
AMGN
GILD
BIIB
REGN
VRTX
BMY
PFE
MRK
JNJ
ABBV
LLY
XOM
CVX
SHEL
BABA
JD
NTES
PDD
VIPS
HTHT
BEKE
EDU
RLX
LI
XPEV
NIO
CPT
TCOM
RBLX
TTD
MELI
PYPL
COIN
HOOD
UPST
SOFI
AFRM
PLTR
SNOW
DDOG
CRWD
PANW
FTNT
OKTA
CHKP
FFIV
HPQ
DELL
HPE
ACN
CGC
ACB
TLRY
CRON
OGI
SPCE
RKLB
ASTS
PLD
AMT
EQIX
CCI
SBAC
TMUS
VZ
EA
TTWO
U
CRSP
EDIT
NTLA
AZN
BNTX
MRNA
TMO
DHR
GOOGL
AAPL
TSLA
NFLX
DIS
CMCSA
PEP
KO
MCD
WMT
COST
TGT
HD
LOW
CHTR
T
SBUX
NKE
MGM
LVS
WYNN
CCL
RCL
NCLH
AAL
UAL
DAL
LUV
BA
GD
LMT
RTX
NOC
HON
GE
MMM
CAT
DE
AGCO
CNH
IR
SNA
TT
ETN
ROK
EMR
AXP
V
MA
BAC
JPM
WFC
C
GS
MS
SCHW
USB
PNC
BBT
STI
KEY
FITB
HBAN
RF
ZION
AXSM
ALKS
TEVA
BMRN
IDXX
EL
LULU
CPRI
PVH
RL
KSS
BBY
DLTR
DG
TJX
ROST
ULTA
MDT
SYK
ISRG
EW
ABT
BSX
XRAY
CTAS
PAYX
ADP
FIS
FISV
Radiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica
globenewswire.com
AZN
BMY
GEHC
IBM
Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica
globenewswire.com
TMO
AMGN
PFE
BMY
GILD
REGN
AZN
LLY
MRK
GSK
European Utilities Accelerate Digital Transformation
businesswire.com
III
ACN
CTSH
IBM
INFY
DXC
TTE
NEE
DUK
SO
PCG
EXC
SRE
AEP
CMS
D
WEC
NI
EIX
ETR
FE
XEL
PNW
LNT
ORA
PEG
MGEE
ES
CWEN
AZN
MTCH
GOOG
GOOGL
MSFT
AMZN
ORCL
SAP
CRM
INTC
AMD
NVDA
CSCO
ATOS
EXLS
HIT
WNS
FRST
TECK
ENHERTU ® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
businesswire.com
AZN
AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
prnewswire.com
AZN
Allergy & Asthma Network Launches National Patient Advocacy Leadership Initiative (PALI)
prnewswire.com
AMGN
AZN
SNY
REGN
ITS Shariah ETF: 25.5% return in first year of trading – world-class Islamic investments developing rapidly in Central Asia
globenewswire.com
AMD
AAPL
AZN
CAT
CVX
XOM
MSFT
NVDA
TSLA